This inventor holds 2 USPTO granted patents. Top assignees: Glycomed, Inc., University of Florida Research Foundation Inc.. Active years: 1998-1999.
Company Filing History:
2 out of 56 
2 out of 3,046 
Years Active: 1998-1999
Title: Cho Tang: Innovator in Matrix Metalloprotease Inhibitors
Introduction
Cho Tang is a notable inventor based in Moraga, CA (US). He has made significant contributions to the field of synthetic matrix metalloprotease inhibitors, with a total of 2 patents to his name. His work focuses on developing treatments for various diseases caused by unwanted mammalian matrix metalloprotease activity.
Latest Patents
Cho Tang's latest patents include a process for preparing synthetic matrix metalloprotease inhibitors. These synthetic inhibitors are designed to treat or prevent diseases such as skin disorders, keratoconus, restenosis, rheumatoid arthritis, wounds, cancer, angiogenesis, and shock. His second patent also addresses synthetic mammalian matrix metalloprotease inhibitors with similar applications.
Career Highlights
Throughout his career, Cho Tang has worked with esteemed organizations, including the University of Florida Research Foundation Inc and Glycomed, Inc. His innovative research has contributed to advancements in medical treatments and therapies.
Collaborations
Some of Cho Tang's notable coworkers include Damian Grobelny and Daniel E Levy. Their collaborative efforts have furthered research in the field of matrix metalloprotease inhibitors.
Conclusion
Cho Tang's work in developing synthetic matrix metalloprotease inhibitors showcases his dedication to advancing medical science. His contributions have the potential to impact the treatment of various diseases significantly.